HistoSonics, Inc.

About HistoSonics, Inc.

HistoSonics, Inc. is a pioneering company in the field of medical technology, dedicated to revolutionising the way we approach tissue ablation and treatment. With a strong focus on innovation, HistoSonics has developed cutting-edge ultrasound technology that enables non-invasive procedures for various medical conditions.

The company’s flagship product utilises histotripsy, a novel ultrasound-based technique that precisely targets and destroys tissue without harming surrounding structures. This breakthrough technology offers significant advantages over traditional surgical methods, including reduced recovery times and minimal side effects.

At HistoSonics, we are committed to advancing healthcare by providing clinicians with effective tools that enhance patient outcomes. Our team of experts works tirelessly to conduct research and development, ensuring that our products meet the highest standards of safety and efficacy.

We envision a future where non-invasive treatments become the standard of care, allowing patients to receive effective therapies with less discomfort and faster recovery. Our mission is to lead the charge in this transformation, making innovative solutions accessible to healthcare providers worldwide.

• Core Values: Innovation, Integrity, Patient-Centric Care
• Vision: To be the global leader in non-invasive medical technologies.
• Commitment: Continuous improvement and excellence in all aspects of our operations.

With headquarters located in the UK, HistoSonics, Inc. is strategically positioned to collaborate with leading medical institutions and researchers. We believe that through partnerships and collaboration, we can accelerate the development of our technologies and bring them to market more efficiently.

As we look to the future, HistoSonics remains dedicated to pushing the boundaries of what is possible in medical technology, ultimately improving the lives of patients around the globe.